Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era

Journal of Clinical Oncology

Volumn 32, Issue 14, 2014, Pages 1419-1426

  Gandaglia, Giorgio ^a,b   Karakiewicz, Pierre I ^a   Sun, Maxine ^a   Montorsi, Francesco ^b   Sammon, Jesse D ^c   Menon, Mani ^c   Chang, Steven L ^d   Choueiri, Toni K ^d   Kibel, Adam S ^d   Konijeti, Ramdev ^d   Nguyen, Paul L ^d   Trinh, Quoc Dien ^d   Hu, Jim C ^e   Kim, Simon P ^f   Sukumar, Shyam ^g  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f YALE UNIVERSITY   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD TRANSFUSION; CANCER SURGERY; CHARLSON COMORBIDITY INDEX; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE COST; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; OPEN RADICAL PROSTATECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REIMBURSEMENT; ROBOT ASSISTED RADICAL PROSTATECTOMY; ROBOTICS; TREATMENT OUTCOME; CANCER REGISTRY; COMPARATIVE STUDY; METHODOLOGY; PROSTATE TUMOR;

AGED; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; SEER PROGRAM;

EID: 84902996520     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.5096     Document Type: Article

References (34)

1. Heidenreich A, Bellmunt J, Bolla M, et al: EAU guidelines on prostate cancer: Part 1 - Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61-71, 2011
2. Lowrance WT, Eastham JA, Savage C, et al: Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol 187:2087-2092, 2012
3. Novara G, Ficarra V, Rosen RC, et al: Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur Urol 62:431-452, 2012
4. Hu JC, Gu X, Lipsitz SR, et al: Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 302:1557-1564, 2009
5. Nguyen PL, Gu X, Lipsitz SR, et al: Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 29:1517-1524, 2011
6. Close A, Robertson C, Rushton S, et al: Comparative cost-effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of men with localised prostate cancer: A health technology assessment from the perspective of the UK National Health Service. Eur Urol 64:361-369, 2013
7. Jacobs BL, Zhang Y, Schroeck FR, et al: Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA 309: 2587-2595, 2013
8. Sukumar S, Roghmann F, Trinh VQ, et al: National trends in hospital-acquired preventable adverse events after major cancer surgery in the USA. BMJ Open 3:6, 2013
9. Schmitges J, Trinh QD, Abdollah F, et al: A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy. Eur Urol 60:564-571, 2011
10. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-18, 2002 (suppl 8)
11. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000 (Pubitemid 32007842)
12. D'Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969-974, 1998 (Pubitemid 28445094)
13. Jacobs BL, Zhang Y, Tan HJ, et al: Hospitalization trends after prostate and bladder surgery: Implications of potential payment reforms. J Urol 189:59-65, 2013
14. Sheets NC, Hendrix LH, Allen IM, et al: Trends in the use of postprostatectomy therapies for patients with prostate cancer: A Surveillance, Epidemiology, and End Results Medicare analysis. Cancer 119:3295-3301, 2013
15. Williams SB, Amarasekera CA, Gu X, et al: Influence of surgeon and hospital volume on radical prostatectomy costs. J Urol 188:2198-2202, 2012
16. Newhouse JP, McClellan M: Econometrics in outcomes research: The use of instrumental variables. Annu Rev Public Health 19:17-34, 1998 (Pubitemid 28279922)
17. Makuc DM, Haglund B, Ingram DD, et al: Health service areas for the United States. Vital Health Stat 2 112:1-102, 1991
18. Lu-Yao G, Albertsen P, Shih W, et al: Failure to report financial disclosure information. JAMA 301:35-36, 2009
19. Tewari A, Sooriakumaran P, Bloch DA, et al: Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: A systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 62:1-15, 2012
20. Trinh QD, Sammon J, Sun M, et al: Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: Results from the nationwide inpatient sample. Eur Urol 61:679-685, 2012
21. Liu JJ, Maxwell BG, Panousis P, et al: Perioperative outcomes for laparoscopic and robotic compared with open prostatectomy using the National Surgical Quality Improvement Program (NSQIP) database. Urology 82:579-583, 2013
22. Trinh QD, Schmitges J, Sun M, et al: Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer 118:1803-1810, 2012
23. Williams SB, Chen MH, D'Amico AV, et al: Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: Likelihood of positive surgical margin(s). Urology 76:1097-1101, 2010
24. Lee EK, Baack J, Duchene DA: Survey of practicing urologists: Robotic versus open radical prostatectomy. Can J Urol 17:5094-5098, 2010
25. Menon M, Bhandari M, Gupta N, et al: Biochemical recurrence following robot-assisted radical prostatectomy: Analysis of 1384 patients with a median 5-year follow-up. Eur Urol 58:838-846, 2010
26. Lowrance WT, Eastham JA, Yee DS, et al: Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis. Cancer 118:3079-3086, 2012
27. Kim SP, Shah ND, Karnes RJ, et al: Hospitalization costs for radical prostatectomy attributable to robotic surgery. Eur Urol 64:11-16, 2013
28. Yu HY, Hevelone ND, Lipsitz SR, et al: Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol 187:1632-1637, 2012
29. Yu HY, Hevelone ND, Lipsitz SR, et al: Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol 187:1392-1398, 2012
30. Sammon JD, Karakiewicz PI, Sun M, et al: Robot-assisted versus open radical prostatectomy: The differential effect of regionalization, procedure volume and operative approach. J Urol 189:1289-1294, 2013
31. Feifer AH, Elkin EB, Lowrance WT, et al: Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 117:3933-3942, 2011
32. Montorsi F, Wilson TG, Rosen RC, et al: Best practices in robot-assisted radical prostatectomy: Recommendations of the Pasadena Consensus Panel. Eur Urol 62:368-381, 2012
33. Barry MJ, Gallagher PM, Skinner JS, et al: Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of Medicare-age men. J Clin Oncol 30:513-518, 2012
34. Lotan Y, Bolenz C, Gupta A, et al: The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons. BJU Int 105:1531-1535, 2010